These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14640894

  • 21. Effects of nitric oxide synthase inhibitors on bone formation in rats.
    Turner CH, Owan I, Jacob DS, McClintock R, Peacock M.
    Bone; 1997 Dec; 21(6):487-90. PubMed ID: 9430237
    [Abstract] [Full Text] [Related]

  • 22. Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein in rat models of non-insulin-dependent diabetes mellitus.
    Takeshita N, Ishida H, Yamamoto T, Koh G, Kurose T, Tsuji K, Okamoto Y, Ikeda H, Seino Y.
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):69-73. PubMed ID: 8447197
    [Abstract] [Full Text] [Related]

  • 23. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin.
    Bagi Z, Koller A.
    J Vasc Res; 2003 Jan; 40(1):47-57. PubMed ID: 12644725
    [Abstract] [Full Text] [Related]

  • 24. Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
    Suzuki K, Ishida H, Takeshita N, Taguchi Y, Sugimoto C, Nosaka K, Seino Y.
    J Diabetes Complications; 1998 Jan; 12(3):176-80. PubMed ID: 9618074
    [Abstract] [Full Text] [Related]

  • 25. L-arginine prevents bone loss and bone collagen breakdown in cyclosporin A-treated rats.
    Fiore CE, Pennisi P, Cutuli VM, Prato A, Messina R, Clementi G.
    Eur J Pharmacol; 2000 Nov 24; 408(3):323-6. PubMed ID: 11090650
    [Abstract] [Full Text] [Related]

  • 26. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin-induced diabetes.
    Ishida H, Seino Y, Takeshita N, Kurose T, Tsuji K, Okamoto Y, Someya Y, Hara K, Akiyama Y, Imura H.
    Acta Endocrinol (Copenh); 1992 Jul 24; 127(1):81-5. PubMed ID: 1387756
    [Abstract] [Full Text] [Related]

  • 27. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
    Hie M, Shimono M, Fujii K, Tsukamoto I.
    Bone; 2007 Dec 24; 41(6):1045-50. PubMed ID: 17916452
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Influence of nitric oxide synthase and kinin antagonists on metabolic parameters in chronic streptozotocin-induced diabetes mellitus.
    González E, Roselló-Catafau J, Xaus C, Jawerbaum A, Novaro V, Gómez G, Gelpí E, Gimeno MA.
    Prostaglandins; 1997 May 24; 53(5):321-36. PubMed ID: 9247972
    [Abstract] [Full Text] [Related]

  • 30. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
    Majithiya JB, Parmar AN, Trivedi CJ, Balaraman R.
    Vascul Pharmacol; 2005 Oct 24; 43(4):260-6. PubMed ID: 16168716
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Failure of the nitric oxide synthase inhibitor to stimulate duodenal bicarbonate secretion in streptozotocin-diabetic rats.
    Takehara K, Tashima K, Kato S, Takeuchi K.
    Life Sci; 1997 Oct 24; 60(17):1505-14. PubMed ID: 9126871
    [Abstract] [Full Text] [Related]

  • 33. An in vivo experimental study on osteopenia in diabetic rats.
    Musumeci G, Loreto C, Clementi G, Fiore CE, Martinez G.
    Acta Histochem; 2011 Oct 24; 113(6):619-25. PubMed ID: 20696468
    [Abstract] [Full Text] [Related]

  • 34. Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis.
    Takizawa M, Suzuki K, Matsubayashi T, Kikuyama M, Suzuki H, Takahashi K, Katsuta H, Mitsuhashi J, Nishida S, Yamaguchi S, Yoshimoto K, Itagaki E, Ishida H.
    Diabetes Res Clin Pract; 2008 Oct 24; 82(1):119-26. PubMed ID: 18774197
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats.
    Bain S, Ramamurthy NS, Impeduglia T, Scolman S, Golub LM, Rubin C.
    Bone; 1997 Aug 24; 21(2):147-53. PubMed ID: 9267690
    [Abstract] [Full Text] [Related]

  • 40. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia.
    Hadjidakis D, Lempert UG, Minne HW, Ziegler R.
    Horm Metab Res; 1993 Feb 24; 25(2):77-81. PubMed ID: 8458612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.